I bring this up as I remember a fascinating security economics paper that examined the economics of spam and its non-obvious conclusions regarding a good intervention point: http://css.csail.mit.edu/6.858/2014/readings/trajectories.pd...
Does anyone here know of a similar study for the drug supply chain?